Use of computed tomography coronary calcium score for prediction of cardiovascular events in cancer patients: a retrospective cohort analysis
-
Published:2024-01-02
Issue:1
Volume:10
Page:
-
ISSN:2057-3804
-
Container-title:Cardio-Oncology
-
language:en
-
Short-container-title:Cardio-Oncology
Author:
Patel Sinal,Franco Francisco X.,McDonald Malcolm,Rivera Carlos,Perez-Villa Bernardo,Collier Patrick,Moudgil Rohit,Gupta Neha,Sadler Diego B.
Abstract
Abstract
Background
CT- coronary calcium score, is one of the most studied and widely available modalities in cardiovascular medicine. Coronary artery calcium score (CACS) is an established predictor of coronary artery disease. The ‘standard of care’ diagnostic modality to measure CACS is ECG-gated Cardiac Multi-Detector Computed Tomography. There is convincing evidence of a strong association between CACS and major cardiovascular (CV) events in asymptomatic individuals. Cancer patients (C) may have a higher risk for CV disease than non-cancer patients (NC) related not only to cancer treatments but also to shared biological factors and pathways. Thus, identifying tools for early detection of CV disease in this population is of utmost importance.
Methods
A retrospective cohort analysis was performed with patients from Cleveland Clinic Florida and Ohio who had CACS from 2017 to 2021. Patients who had cancer diagnosis prior to CACS were matched to NC for age and sex. CV events after their index CACS events were compared between C and NC, and matched control and propensity analysis were conducted.
Results
Ten thousand seven hundred forty-two patients had CACS; 703 cancer patients had CACS and were eligible. Extensive CACS (> 400) were significantly higher in cancer, 94 (13.37%) vs non-cancer patients, 76 (10.83%), P = 0.011. Furthermore, after propensity matched analysis, CACS > 400 was 14.8% in C vs 9.6% in NC, P = < 0.05. CV events were similar in both cohorts (p = NS), despite less CV risk factors in cancer patients (P = < 0.05). For the combined moderate (101–400) & extensive (> 400) CACS, the prevalence of stroke and peripheral arterial disease, a marker of systemic atherosclerosis, was significantly higher in patients with cancer (P < 0.01).
Conclusions
Despite having fewer CV risk factors in our study, similar CACS in cancer patients are suggestive of a higher prevalence of CV disease independent of traditional risk factors. High CACS and the overall prevalence of vascular events were more frequent in patients with cancer. Higher prevalence of peripheral arterial disease and cerebrovascular accident further suggests the increased atherosclerotic burden in C.
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Oncology
Reference39 articles.
1. WHO, World Health Organization, Keyfacts Cardiovascular Diseases (CVDs), 2017. Accessed March 18, 2019. 2. Murphy SL, Kochanek KD, Xu J, Arias E. Mortality in the United States, 2020. NCHS Data Brief. 2021;427:1–8. 3. Wang FM, Reiter-Brennan C, Dardari Z, Marshall CH, Nasir K, Miedema MD, Berman DS, Rozanski A, Rumberger JA, Budoff MJ, Dzaye O, Blaha MJ. Association between coronary artery calcium and cardiovascular disease as a supporting cause in cancer: The CAC consortium. Am J Prev Cardiol. 2020;12(4): 100119. https://doi.org/10.1016/j.ajpc.2020.100119. 4. Mladosievicova B, Petrikova L, Valaskova Z, Bernadic M Jr, Chovanec M, Mego M, Bernadic M Sr. Atherosclerosis in cancer patients. Bratisl Lek Listy. 2019;120(9):636–40. https://doi.org/10.4149/BLL_2019_105. 5. Florido R, Daya NR, Ndumele CE, Koton S, Russell SD, Prizment A, Blumenthal RS, Matsushita K, Mok Y, Felix AS, Chores J, Joshu CE, Platz EA, Selvin E. Cardiovascular disease risk among cancer survivors: the Atherosclerosis Risk In Communities (ARIC) Study. J Am Coll Cardiol. 2022;80(1):22–32. https://doi.org/10.1016/j.jacc.2022.04.042.
|
|